IN8bio Inc (INAB) with a beta value of -0.23 appears to be a promising investment opportunity.

IN8bio Inc (NASDAQ: INAB) on November 20, 2023, started off the session at the price of $0.91, plunging -4.95% from the previous trading day. During the day, the shares moved up to $0.92 and dropped to $0.851 before settling in for the closing price of $0.91. Within the past 52 weeks, INAB’s price has moved between $0.88 and $3.95.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


The company achieved an average annual earnings per share of 29.41%. With a float of $21.05 million, this company’s outstanding shares have now reached $24.55 million.

Considering the fact that the conglomerate employs 26 people, you should pay attention to its efficiency factor.

IN8bio Inc (INAB) Breakdown of a Key Holders of the stock

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of IN8bio Inc is 34.22%, while institutional ownership is 7.76%. The most recent insider transaction that took place on Sep 13, was worth 2,375. In this transaction Director of this company bought 2,500 shares at a rate of $0.95, taking the stock ownership to the 2,500 shares. Before that another transaction happened on Aug 25, when Company’s Chief Financial Officer bought 1,000 for $1.03, making the entire transaction worth $1,030. This insider now owns 6,263 shares in total.

IN8bio Inc (INAB) Recent Fiscal highlights

As on 9/29/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.23 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.24) by $0.01. This company achieved a return on equity of -93.64. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 29.41% per share during the next fiscal year.

IN8bio Inc (NASDAQ: INAB) Trading Performance Indicators

IN8bio Inc (INAB) is currently performing well based on its current performance indicators. A quick ratio of 3.53 was reported for the most recent quarter.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.12, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.58 in one year’s time.

Technical Analysis of IN8bio Inc (INAB)

Compared to the last year’s volume of 1.15 million, its volume of 0.36 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 11.81%. Additionally, its Average True Range was 0.09.

During the past 100 days, IN8bio Inc’s (INAB) raw stochastic average was set at 1.49%, which indicates a significant decrease from 5.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.45% in the past 14 days, which was lower than the 73.32% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.0005, while its 200-day Moving Average is $1.5196. Nevertheless, the first resistance level for the watch stands at $0.9063 in the near term. At $0.9477, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9753. If the price goes on to break the first support level at $0.8373, it is likely to go to the next support level at $0.8097. Now, if the price goes above the second support level, the third support stands at $0.7683.

IN8bio Inc (NASDAQ: INAB) Key Stats

Market capitalization of the company is 27.67 million based on 31,991K outstanding shares. Right now, sales total 0 K and income totals -28,520 K. The company made 0 K in profit during its latest quarter, and -7,170 K in sales during its previous quarter.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Zillow Group Inc (Z)’s latest performance is not what we had anticipated

Zillow Group Inc (NASDAQ: Z) on November 27, 2023, started off the session at the price of $39.97, soaring 2.72% from the previous trading...

40.71% percent quarterly performance for Fresh Vine Wine Inc (VINE) is not indicative of the underlying story

November 27, 2023, Fresh Vine Wine Inc (AMEX: VINE) trading session started at the price of $0.61, that was 7.22% jump from the session...

Infosys Ltd ADR (INFY) is 1.37% away from 50-day simple Moving Average despite all headwinds

On November 27, 2023, Infosys Ltd ADR (NYSE: INFY) opened at $17.34, lower -0.57% from the last session. During the day, the shares moved...


Please enter your comment!
Please enter your name here